keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Verapamil (CP-16533-1) is a calcium channel blocker and an orally active and effective inhibitor of P-gp. Verapamil inhibits CYP3A4 and can be used in studies about the treatment of high blood pressure, heart arrhythmias, and angina research.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 7,000 | |||
25 mg | 在庫あり | ¥ 11,000 | |||
50 mg | 在庫あり | ¥ 15,500 | |||
100 mg | 在庫あり | ¥ 22,500 | |||
200 mg | 在庫あり | ¥ 33,500 | |||
500 mg | 在庫あり | ¥ 56,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Verapamil (CP-16533-1) is a calcium channel blocker and an orally active and effective inhibitor of P-gp. Verapamil inhibits CYP3A4 and can be used in studies about the treatment of high blood pressure, heart arrhythmias, and angina research. |
別名 | NSC 135784, NSC-135784, CP-16533-1, (±)-Verapamil |
分子量 | 454.6 |
分子式 | C27H38N2O4 |
CAS No. | 52-53-9 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (98.99 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Verapamil 52-53-9 Membrane transporter/Ion channel Metabolism Neuroscience P-gp Calcium Channel P450 inhibit NSC 135784 Pgp antiarrhythmic CYP3A4 Cytochrome P450 Palbociclib CYPs pressure ABCB1 angina Multidrug resistance protein 1 Ca2+ channels NSC-135784 lysosomotropic MDR1 Ca channels CP-16533-1 Cluster of differentiation 243 high NSC135784 Inhibitor P-glycoprotein CD243 (±)-Verapamil blood inhibitor